Balchem BCPC Human Nutrition and Health — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Balchem in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Balchem's human nutrition and health — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Balchem's human nutrition and health — operating income (loss)?
- Balchem (BCPC) reported human nutrition and health — operating income (loss) of $40.02M in Q1 2026.
- How has Balchem's human nutrition and health — operating income (loss) changed year-over-year?
- Balchem's human nutrition and health — operating income (loss) increased by 5.4% year-over-year, from $37.97M to $40.02M.
- What is the long-term trend for Balchem's human nutrition and health — operating income (loss)?
- Over 3 years (2022 to 2025), Balchem's human nutrition and health — operating income (loss) has grown at a 23.3% compound annual growth rate (CAGR), from $82.13M to $153.91M.
- What does human nutrition and health — operating income (loss) mean?
- Measures the profitability of the Human Nutrition and Health segment after deducting both cost of sales and operating expenses from net sales. It provides a clear view of the segment's operational performance and its contribution to the company's total earnings. This metric is a key indicator of the segment's ability to generate sustainable profit from its core business activities.